Zeitschriftenartikel zum Thema „Insulin-like growth factor I Physiology“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Insulin-like growth factor I Physiology" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Holly, Jeff M. P., und Claire M. Perks. „Insulin-Like Growth Factor Physiology“. Endocrinology and Metabolism Clinics of North America 41, Nr. 2 (Juni 2012): 249–63. http://dx.doi.org/10.1016/j.ecl.2012.04.009.
Yakar, Shoshana, und Martin L. Adamo. „Insulin-Like Growth Factor 1 Physiology“. Endocrinology and Metabolism Clinics of North America 41, Nr. 2 (Juni 2012): 231–47. http://dx.doi.org/10.1016/j.ecl.2012.04.008.
Rosen, Clifford J. „Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications“. Clinical Chemistry 45, Nr. 8 (01.08.1999): 1384–90. http://dx.doi.org/10.1093/clinchem/45.8.1384.
Pollak, Michael. „Insulin-like growth factor physiology and neoplasia“. Growth Hormone & IGF Research 10 (Januar 2000): S6—S7. http://dx.doi.org/10.1016/s1096-6374(00)90002-9.
Holly, Jeff M. P., Claire M. Perks und Claire E. H. Stewart. „Overview of insulin-like growth factor physiology“. Growth Hormone & IGF Research 10 (Januar 2000): S8—S9. http://dx.doi.org/10.1016/s1096-6374(00)90003-0.
Roith, Derek Le. „The Insulin-Like Growth Factor System“. Experimental Diabesity Research 4, Nr. 4 (2003): 205–12. http://dx.doi.org/10.1155/edr.2003.205.
Pollak, M. „Insulin-like growth factor physiology and cancer risk“. European Journal of Cancer 36, Nr. 10 (Juni 2000): 1224–28. http://dx.doi.org/10.1016/s0959-8049(00)00102-7.
Gabbitas, Bari, und Ernesto Canalis. „Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts“. American Journal of Physiology-Endocrinology and Metabolism 275, Nr. 2 (01.08.1998): E222—E228. http://dx.doi.org/10.1152/ajpendo.1998.275.2.e222.
Sheppard, M. S., und R. M. Bala. „Insulin-like growth factor inhibition of growth hormone secretion“. Canadian Journal of Physiology and Pharmacology 64, Nr. 5 (01.05.1986): 525–30. http://dx.doi.org/10.1139/y86-087.
Sowers, James R. „Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology“. Hypertension 29, Nr. 3 (März 1997): 691–99. http://dx.doi.org/10.1161/01.hyp.29.3.691.
Yoshimura, Yasunori. „Insulin-like Growth Factors and Ovarian Physiology“. Journal of Obstetrics and Gynaecology Research 24, Nr. 5 (Oktober 1998): 305–23. http://dx.doi.org/10.1111/j.1447-0756.1998.tb00103.x.
Herington, Adrian C. „Insulin-like growth factors: biochemistry and physiology“. Baillière's Clinical Endocrinology and Metabolism 5, Nr. 4 (Dezember 1991): 531–51. http://dx.doi.org/10.1016/s0950-351x(10)80002-3.
Yip, Cecil C., Helga Hsu, Jerrold M. Olefsky und Lynn Seely. „Preparation of insulin-like growth factor I and photoaffinity labeling of insulin-like growth factor I receptor“. Peptides 14, Nr. 2 (März 1993): 325–30. http://dx.doi.org/10.1016/0196-9781(93)90048-l.
Hammerman, M. R. „The growth hormone-insulin-like growth factor axis in kidney“. American Journal of Physiology-Renal Physiology 257, Nr. 4 (01.10.1989): F503—F514. http://dx.doi.org/10.1152/ajprenal.1989.257.4.f503.
Ashton, Nick. „Insulin-like growth factor, nephrogenesis and hypertension“. Journal of Hypertension 24, Nr. 9 (September 2006): 1707–9. http://dx.doi.org/10.1097/01.hjh.0000242392.22720.e0.
Roberts, CT,, und D. LeRoith. „Interactions in the Insulin-Like Growth Factor Signaling System“. Physiology 7, Nr. 2 (01.04.1992): 69–72. http://dx.doi.org/10.1152/physiologyonline.1992.7.2.69.
Boni-Schnetzler, M., C. Schmid, P. J. Meier und E. R. Froesch. „Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes“. American Journal of Physiology-Endocrinology and Metabolism 260, Nr. 6 (01.06.1991): E846—E851. http://dx.doi.org/10.1152/ajpendo.1991.260.6.e846.
Fryburg, D. A. „Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism“. American Journal of Physiology-Endocrinology and Metabolism 267, Nr. 2 (01.08.1994): E331—E336. http://dx.doi.org/10.1152/ajpendo.1994.267.2.e331.
Hussain, MA, O. Schmitz und ER Froesch. „Growth Hormone, Insulin, and Insulin-Like Growth Factor I: Revisiting the Food and Famine Theory“. Physiology 10, Nr. 2 (01.04.1995): 81–86. http://dx.doi.org/10.1152/physiologyonline.1995.10.2.81.
Hammerman, M. R., und S. B. Miller. „The growth hormone insulin-like growth factor axis in kidney revisited“. American Journal of Physiology-Renal Physiology 265, Nr. 1 (01.07.1993): F1—F14. http://dx.doi.org/10.1152/ajprenal.1993.265.1.f1.
Röttgering, Bas T., und Karoly Szuhai. „Insulin-Like Growth Factor 2 in Physiology, Cancer, and Cancer Treatment“. OBM Genetics 3, Nr. 4 (14.05.2019): 1. http://dx.doi.org/10.21926/obm.genet.1904096.
Froesch, E. Rudolf, Mehboob A. Hussain, Christoph Schmid und Jürgen Zapf. „Insulin-like Growth Factor I: Physiology, Metabolic Effects and Clinical Uses“. Diabetes / Metabolism Reviews 12, Nr. 3 (Oktober 1996): 195–215. http://dx.doi.org/10.1002/(sici)1099-0895(199610)12:3<195::aid-dmr164>3.0.co;2-g.
Franklin, S. C., M. Moulton, G. A. Sicard, M. R. Hammerman und S. B. Miller. „Insulin-like growth factor I preserves renal function postoperatively“. American Journal of Physiology-Renal Physiology 272, Nr. 2 (01.02.1997): F257—F259. http://dx.doi.org/10.1152/ajprenal.1997.272.2.f257.
Miller, S. C., und C. M. Bagi. „Systemic effects of transforming growth factor-β and insulin-like growth factor“. Bone 19, Nr. 3 (September 1996): 153. http://dx.doi.org/10.1016/s8756-3282(96)90821-2.
Thabet, M. A., A. Challa, W. Chan, F. Liu, R. L. Hintz und J. C. Chan. „Insulin-like growth factor and growth hormone receptor in nephrotic rats“. American Journal of Physiology-Endocrinology and Metabolism 266, Nr. 1 (01.01.1994): E102—E106. http://dx.doi.org/10.1152/ajpendo.1994.266.1.e102.
Conover, Cheryl A. „Insulin-like growth factor-binding proteins and bone metabolism“. American Journal of Physiology-Endocrinology and Metabolism 294, Nr. 1 (Januar 2008): E10—E14. http://dx.doi.org/10.1152/ajpendo.00648.2007.
Mukherjee, Aditi, Damir Alzhanov und Peter Rotwein. „Defining human insulin-like growth factor I gene regulation“. American Journal of Physiology-Endocrinology and Metabolism 311, Nr. 2 (01.08.2016): E519—E529. http://dx.doi.org/10.1152/ajpendo.00212.2016.
Eliakim, Alon, Youngman Oh und Dan Michael Cooper. „Effect of single wrist exercise on fibroblast growth factor-2, insulin-like growth factor, and growth hormone“. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 279, Nr. 2 (01.08.2000): R548—R553. http://dx.doi.org/10.1152/ajpregu.2000.279.2.r548.
Rutanen, Eeva-Marja. „Insulin-Like Growth Factor Binding Protein-1“. Seminars in Reproductive Medicine 10, Nr. 02 (Mai 1992): 154–63. http://dx.doi.org/10.1055/s-2007-1018871.
Butler, Andrew A., Shoshana Yakar und Derek LeRoith. „Insulin-Like Growth Factor-I: Compartmentalization Within the Somatotropic Axis?“ Physiology 17, Nr. 2 (April 2002): 82–85. http://dx.doi.org/10.1152/nips.01351.2001.
Bach, Leon A., Ping Fu und Zhiyong Yang. „Insulin-like growth factor-binding protein-6 and cancer“. Clinical Science 124, Nr. 4 (31.10.2012): 215–29. http://dx.doi.org/10.1042/cs20120343.
Bosche, William J., Daina Z. Ewton und James R. Florini. „Transforming growth factor-beta isoform expression in insulin-like growth factor stimulated myogenesis“. Journal of Cellular Physiology 164, Nr. 2 (August 1995): 324–33. http://dx.doi.org/10.1002/jcp.1041640213.
Belfiore, Antonino, Francesco Frasca, Giuseppe Pandini, Laura Sciacca und Riccardo Vigneri. „Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease“. Endocrine Reviews 30, Nr. 6 (01.10.2009): 586–623. http://dx.doi.org/10.1210/er.2008-0047.
Friedrich, Nele, Torben Jørgensen, Henri Wallaschofski und Allan Linneberg. „911 THE EFFECT OF INSULIN-LIKE GROWTH FACTOR 1 AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 ON BLOOD PRESSURE“. Journal of Hypertension 30 (September 2012): e263. http://dx.doi.org/10.1097/01.hjh.0000420853.64612.b5.
Scott, Carolyn D., und Jocelyn Weiss. „Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells“. Journal of Cellular Physiology 182, Nr. 1 (Januar 2000): 62–68. http://dx.doi.org/10.1002/(sici)1097-4652(200001)182:1<62::aid-jcp7>3.0.co;2-x.
Park, Jung H. Y., Mark R. Corkins, Jon A. Vanderhoof, Nia M. Caruso, Marjorie J. Hrbek, Beverly S. Schaffer, Dorothy H. Slentz, Robert H. McCusker und Richard G. MacDonald. „Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation“. Journal of Cellular Physiology 166, Nr. 2 (Februar 1996): 396–406. http://dx.doi.org/10.1002/(sici)1097-4652(199602)166:2<396::aid-jcp18>3.0.co;2-9.
Werner, Haim, und Ilan Bruchim. „The insulin-like growth factor-I receptor as an oncogene“. Archives of Physiology and Biochemistry 115, Nr. 2 (Mai 2009): 58–71. http://dx.doi.org/10.1080/13813450902783106.
Karadag, A. S., D. T. Ertugrul, E. Tutal und K. O. Akin. „Short-term isotretinoin treatment decreases insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels: does isotretinoin affect growth hormone physiology?“ British Journal of Dermatology 162, Nr. 4 (01.02.2010): 798–802. http://dx.doi.org/10.1111/j.1365-2133.2009.09618.x.
Higashi, Yusuke, Sergiy Sukhanov, Sampath Parthasarathy und Patrice Delafontaine. „The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor“. American Journal of Physiology-Heart and Circulatory Physiology 295, Nr. 4 (Oktober 2008): H1684—H1689. http://dx.doi.org/10.1152/ajpheart.00548.2008.
Han, Ho Jae, Chang Won Kang und Soo Hyun Park. „TISSUE-SPECIFIC REGULATION OF INSULIN-LIKE GROWTH FACTORS AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS IN MALE DIABETIC RATS IN VIVO AND IN VITRO“. Clinical and Experimental Pharmacology and Physiology 33, Nr. 12 (Dezember 2006): 1172–79. http://dx.doi.org/10.1111/j.1440-1681.2006.04495.x.
Hayakawa, Tetsuo, Takaharu Kondo, Tokimune Shibata, Motoji Kitagawa, Hideki Ono, Yuzo Sakai, Katsumoto Kato et al. „Serum insulin-like growth factor II in chronic liver disease“. Digestive Diseases and Sciences 34, Nr. 3 (März 1989): 338–42. http://dx.doi.org/10.1007/bf01536252.
Olanrewaju, Hammed A., Eric D. Sanzenbacher und Edward R. Seidel. „Insulin-like growth factor I in suckling rat gastric contents“. Digestive Diseases and Sciences 41, Nr. 7 (Juli 1996): 1392–97. http://dx.doi.org/10.1007/bf02088564.
Cappon, J., J. A. Brasel, S. Mohan und D. M. Cooper. „Effect of brief exercise on circulating insulin-like growth factor I“. Journal of Applied Physiology 76, Nr. 6 (01.06.1994): 2490–96. http://dx.doi.org/10.1152/jappl.1994.76.6.2490.
Muhammad, Tahir, Mengjing Li, Jianfeng Wang, Tao Huang, Shigang Zhao, Han Zhao, Hongbin Liu und Zi-Jiang Chen. „Roles of insulin-like growth factor II in regulating female reproductive physiology“. Science China Life Sciences 63, Nr. 6 (10.04.2020): 849–65. http://dx.doi.org/10.1007/s11427-019-1646-y.
Haus, Erhard, E. Haus, L. Dumitriu, G. Y. Nicolau, S. Bologa und L. Sackett-Lundeen. „CIRCADIAN RHYTHMS OF BASIC FIBROBLAST GROWTH FACTOR (bFGF), EPIDERMAL GROWTH FACTOR (EGF), INSULIN-LIKE GROWTH FACTOR-1 (IGF-1), INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3), CORTISOL, AND MELATONIN IN WOMEN WITH BREAST CANCER“. Chronobiology International 18, Nr. 4 (Januar 2001): 709–27. http://dx.doi.org/10.1081/cbi-100106083.
Salehi, Zivar, Farhad Mashayekhi, Mohammad Naji und Sareh Pandamooz. „Insulin-like growth factor-1 and insulin-like growth factor binding proteins in cerebrospinal fluid during the development of mouse embryos“. Journal of Clinical Neuroscience 16, Nr. 7 (Juli 2009): 950–53. http://dx.doi.org/10.1016/j.jocn.2008.09.018.
GAUSSIN, V., und C. DEPRE. „Myostatin, the cardiac chalone of insulin-like growth factor-1“. Cardiovascular Research 68, Nr. 3 (01.12.2005): 347–49. http://dx.doi.org/10.1016/j.cardiores.2005.09.007.
Radosavljevic, Tatjana, Vera Todorovic, Danijela Vucevic und Branka Sikic. „The growth hormone axis and insulin-like growth factors“. Medical review 58, Nr. 11-12 (2005): 558–62. http://dx.doi.org/10.2298/mpns0512558r.
Vardy, Daniel A., Csaba Kari, Gerald S. Lazarus, Pamela J. Jensen, Asher Zilberstein, Gregory D. Plowman und Ulrich Rodeck. „Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1“. Journal of Cellular Physiology 163, Nr. 2 (Mai 1995): 257–65. http://dx.doi.org/10.1002/jcp.1041630206.
Leibush, B., M. Párrizas, I. Navarro, Y. Lappova, M. A. Maestro, M. Encinas, E. M. Plisetskaya und J. Gutiérrez. „Insulin and insulin-like growth factor-I receptors in fish brain“. Regulatory Peptides 61, Nr. 2 (Februar 1996): 155–61. http://dx.doi.org/10.1016/0167-0115(95)00154-9.